GRP
RVNC

Global Retirement Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Global Retirement Partners’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$556 Buy
+183
New +$797 ﹤0.01% 3382
2023
Q2 		– Sell
-9
Closed -$302 – 3264
2023
Q1 		$302 Buy
+9
New +$281 ﹤0.01% 3034

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Global Retirement Partners's RVNC Position: Q4 2024 in Review

Global Retirement Partners opened a new position in Revance Therapeutics, Inc. (RVNC) in Q4 2024: 183 shares worth $556. The stake represents ﹤0.01% of the portfolio and ranks #3382 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RVNC as recently as Q1 2023.

Global Retirement Partners first reported a position in RVNC in Q1 2023 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Global Retirement Partners held 183 shares of Revance Therapeutics, Inc. worth $556 as of Q4 2024.
  • Revance Therapeutics, Inc. was a new Global Retirement Partners position in Q4 2024.
  • Revance Therapeutics, Inc. made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #3382 holding.
  • Global Retirement Partners first reported a position in Revance Therapeutics, Inc. in Q1 2023 and has held it in 2 quarters since.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.